21 Recruiting Studies Using Idarubicin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Idarubicin
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
📍 Children's Hospital of Central California — Madera, California
Acute Myeloid Leukemia
View Study & Checklist ➔Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
View Study & Checklist ➔Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
📍 City of Hope — Duarte, California
Acute Myeloid Leukemia
View Study & Checklist ➔BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
📍 Los Angeles General Medical Center — Los Angeles, California
Acute Myeloid Leukemia
View Study & Checklist ➔Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
📍 City of Hope — Duarte, California
Newly Diagnosed Acute Myeloid Leukemia (AML)
View Study & Checklist ➔Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
📍 University of Arizona Cancer Center - North Campus — Tucson, Arizona
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist ➔Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
📍 UT MD Anderson — Houston, Texas
Myeloid Leukemia
View Study & Checklist ➔Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist ➔UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
📍 Texas Children's Cancer and Hematology Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
View Study & Checklist ➔Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Acute Biphenotypic Leukemia
View Study & Checklist ➔Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
AML
View Study & Checklist ➔CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
Acute Myeloid Leukemia
View Study & Checklist ➔Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
High Risk Myelodysplastic Syndrome
View Study & Checklist ➔Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔